What is MWAI's health score?

MedWellAI, Inc. (MWAI) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MWAI's estimated fair value?

Based on our 5-year discounted cash flow model, MedWellAI, Inc.'s estimated fair value is $2.4 per share, representing a 742.4% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MWAI undervalued or overvalued?

Our model currently rates MWAI as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

MedWellAI, Inc. (MWAI)

Financials Undervalued low mixed

$0.29

Updated: 2026-07-16

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

60 Healthy

Relative Value

50 Mixed

Capital Allocation

40 Weak

Risk Management

50 Mixed

Est. Fair Value $2.4

DCF Upside +742.4%

Sector Rank #3542 of 12160

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Industry Related Stocks

Athena Bitcoin Global (ABIT) American Bitcoin Corp. (ABTC) Abits Group Inc (ABTS) AIxCrypto Holdings, Inc. (AIXC) Amber International Holding Ltd (AMBR) AMTD IDEA GROUP (AMTD)

See all Financials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.